Pacira Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Pacira Biosciences

03/05/2023 14:32

* Pacira Biosciences Inc  PCRX.OQ  reported quarterly
adjusted
earnings of 53 cents​​ per share for the quarter ended in March.
The mean expectation of nine analysts for the quarter was
for earnings of 62 cents per share.
    * Revenue rose 1.5% to $160.34 million from a year ago;
analysts
expected $158.84 million. 
    * Pacira Biosciences Inc's reported EPS for the quarter was
a loss
of 43 cents​.
    * The mean earnings estimate of analysts had fallen by
about 20.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Pacira Biosciences Inc shares had risen by 13.8% this
quarter and gained 20.3% so far this year.
    * The company reported quarterly net income of $19.54
million.
    * Wall Street's median 12-month price target for Pacira
Biosciences Inc is $60.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
3 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.62           0.53           Missed
 Dec. 31 2022      0.83           0.80           Missed
 Sep. 30 2022      0.76           0.64           Missed
 Jun. 30 2022      0.85           0.51           Missed